Caribou Biosciences, Inc.CRBUNASDAQ
Loading
Revenue PerformanceStable
Percentile Rank50
3Y CAGR-7.0%
5Y CAGR-2.0%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-7.0%/yr
Annual compound
5Y CAGR
-2.0%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$11.16M+11.7%
2024$9.99M-71.0%
2023$34.48M+148.9%
2022$13.85M+44.3%
2021$9.60M-22.4%
2020$12.36M+113.6%
2019$5.79M-